TY - JOUR AU - Smolen, J. S. AU - Landewe, R. AU - Bijlsma, J. AU - Burmester, G. AU - Chatzidionysiou, K. AU - Dougados, M. PY - 2017 DA - 2017// TI - EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update JO - Ann Rheum Dis VL - 76 UR - https://doi.org/10.1136/annrheumdis-2016-210715 DO - 10.1136/annrheumdis-2016-210715 ID - Smolen2017 ER - TY - JOUR AU - Singh, J. A. AU - Saag, K. G. AU - Bridges, S. L. AU - Akl, E. A. AU - Bannuru, R. R. AU - Sullivan, M. C. PY - 2016 DA - 2016// TI - 2015 American College of Rheumatology Guideline for the treatment of rheumatoid arthritis JO - Arthritis Rheumatol VL - 68 ID - Singh2016 ER - TY - JOUR AU - Gaujoux-Viala, C. AU - Gossec, L. AU - Cantagrel, A. AU - Dougados, M. AU - Fautrel, B. AU - Mariette, X. PY - 2014 DA - 2014// TI - Recommendations of the French Society for Rheumatology for managing rheumatoid arthritis JO - Joint Bone Spine VL - 81 UR - https://doi.org/10.1016/j.jbspin.2014.05.002 DO - 10.1016/j.jbspin.2014.05.002 ID - Gaujoux-Viala2014 ER - TY - JOUR AU - Albrecht, K. AU - Kruger, K. AU - Wollenhaupt, J. AU - Alten, R. AU - Backhaus, M. AU - Baerwald, C. PY - 2014 DA - 2014// TI - German guidelines for the sequential medical treatment of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs JO - Rheumatol Int VL - 34 UR - https://doi.org/10.1007/s00296-013-2848-3 DO - 10.1007/s00296-013-2848-3 ID - Albrecht2014 ER - TY - JOUR AU - Bykerk, V. P. AU - Akhavan, P. AU - Hazlewood, G. S. AU - Schieir, O. AU - Dooley, A. AU - Haraoui, B. PY - 2012 DA - 2012// TI - Canadian rheumatology association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs JO - J Rheumatol VL - 39 UR - https://doi.org/10.3899/jrheum.110207 DO - 10.3899/jrheum.110207 ID - Bykerk2012 ER - TY - STD TI - (UK) NCCfCC. Rheumatoid arthritis: national clinical guideline for management and treatment in adults: National institute for health and clinical excellence: guidance. National collaborating centre for chronic conditions (UK). London: Royal College of Physicians (UK); 2009. ID - ref6 ER - TY - JOUR AU - Smolen, J. S. AU - Breedveld, F. C. AU - Burmester, G. R. AU - Bykerk, V. AU - Dougados, M. AU - Emery, P. PY - 2016 DA - 2016// TI - Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force JO - Ann Rheum Dis VL - 75 UR - https://doi.org/10.1136/annrheumdis-2015-207524 DO - 10.1136/annrheumdis-2015-207524 ID - Smolen2016 ER - TY - JOUR AU - Huizinga, T. AU - Knevel, R. PY - 2015 DA - 2015// TI - Rheumatoid arthritis: 2014 treat-to-target RA recommendations--strategy is key JO - Nat Rev Rheumatol VL - 11 UR - https://doi.org/10.1038/nrrheum.2015.98 DO - 10.1038/nrrheum.2015.98 ID - Huizinga2015 ER - TY - JOUR AU - Alemao, E. AU - Joo, S. AU - Kawabata, H. AU - Al, M. J. AU - Allison, P. D. AU - Rutten-van Molken, M. P. PY - 2016 DA - 2016// TI - Effects of achieving target measures in rheumatoid arthritis on functional status, quality of life, and resource utilization: analysis of clinical practice data JO - Arthritis Care Res VL - 68 UR - https://doi.org/10.1002/acr.22678 DO - 10.1002/acr.22678 ID - Alemao2016 ER - TY - JOUR AU - van Nies, J. A. AU - Tsonaka, R. AU - Gaujoux-Viala, C. AU - Fautrel, B. AU - van der Helm-van Mil, A. H. PY - 2015 DA - 2015// TI - Evaluating relationships between symptom duration and persistence of rheumatoid arthritis: does a window of opportunity exist? Results on the Leiden early arthritis clinic and ESPOIR cohorts JO - Ann Rheum Dis VL - 74 UR - https://doi.org/10.1136/annrheumdis-2014-206047 DO - 10.1136/annrheumdis-2014-206047 ID - van Nies2015 ER - TY - JOUR AU - Felson, D. T. AU - Smolen, J. S. AU - Wells, G. AU - Zhang, B. AU - van Tuyl, L. H. AU - Funovits, J. PY - 2011 DA - 2011// TI - American College of Rheumatology/European league against rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials JO - Ann Rheum Dis VL - 70 UR - https://doi.org/10.1136/ard.2011.149765 DO - 10.1136/ard.2011.149765 ID - Felson2011 ER - TY - JOUR AU - Prevoo, M. L. AU - van Gestel, A. M. AU - van, T. H. M. A. AU - van Rijswijk, M. H. AU - van de Putte, L. B. AU - van Riel, P. L. PY - 1996 DA - 1996// TI - Remission in a prospective study of patients with rheumatoid arthritis. American rheumatism association preliminary remission criteria in relation to the disease activity score JO - Br J Rheumatol VL - 35 UR - https://doi.org/10.1093/rheumatology/35.11.1101 DO - 10.1093/rheumatology/35.11.1101 ID - Prevoo1996 ER - TY - JOUR AU - Smolen, J. S. AU - Breedveld, F. C. AU - Schiff, M. H. AU - Kalden, J. R. AU - Emery, P. AU - Eberl, G. PY - 2003 DA - 2003// TI - A simplified disease activity index for rheumatoid arthritis for use in clinical practice JO - Rheumatology VL - 42 UR - https://doi.org/10.1093/rheumatology/keg072 DO - 10.1093/rheumatology/keg072 ID - Smolen2003 ER - TY - JOUR AU - Aletaha, D. AU - Ward, M. M. AU - Machold, K. P. AU - Nell, V. P. AU - Stamm, T. AU - Smolen, J. S. PY - 2005 DA - 2005// TI - Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states JO - Arthritis Rheum VL - 52 UR - https://doi.org/10.1002/art.21235 DO - 10.1002/art.21235 ID - Aletaha2005 ER - TY - JOUR AU - Sheehy, C. AU - Evans, V. AU - Hasthorpe, H. AU - Mukhtyar, C. PY - 2014 DA - 2014// TI - Revising DAS28 scores for remission in rheumatoid arthritis JO - Clin Rheumatol VL - 33 UR - https://doi.org/10.1007/s10067-013-2468-z DO - 10.1007/s10067-013-2468-z ID - Sheehy2014 ER - TY - JOUR AU - Schipper, L. G. AU - van Hulst, L. T. AU - Grol, R. AU - van Riel, P. L. AU - Hulscher, M. E. AU - Fransen, J. PY - 2010 DA - 2010// TI - Meta-analysis of tight control strategies in rheumatoid arthritis: protocolized treatment has additional value with respect to the clinical outcome JO - Rheumatology VL - 49 UR - https://doi.org/10.1093/rheumatology/keq195 DO - 10.1093/rheumatology/keq195 ID - Schipper2010 ER - TY - JOUR AU - Knevel, R. AU - Schoels, M. AU - Huizinga, T. W. AU - Aletaha, D. AU - Burmester, G. R. AU - Combe, B. PY - 2010 DA - 2010// TI - Current evidence for a strategic approach to the management of rheumatoid arthritis with disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis JO - Ann Rheum Dis VL - 69 UR - https://doi.org/10.1136/ard.2009.126748 DO - 10.1136/ard.2009.126748 ID - Knevel2010 ER - TY - JOUR AU - Jurgens, M. S. AU - Welsing, P. M. AU - Jacobs, J. W. PY - 2012 DA - 2012// TI - Overview and analysis of treat-to-target trials in rheumatoid arthritis reporting on remission JO - Clin Exp Rheumatol VL - 30 ID - Jurgens2012 ER - TY - JOUR AU - Bykerk, V. P. AU - Keystone, E. C. AU - Kuriya, B. AU - Larche, M. AU - Thorne, J. C. AU - Haraoui, B. PY - 2013 DA - 2013// TI - Achieving remission in clinical practice: lessons from clinical trial data JO - Clin Exp Rheumatol VL - 31 ID - Bykerk2013 ER - TY - JOUR AU - Stoffer, M. A. AU - Schoels, M. M. AU - Smolen, J. S. AU - Aletaha, D. AU - Breedveld, F. C. AU - Burmester, G. PY - 2016 DA - 2016// TI - Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update JO - Ann Rheum Dis VL - 75 UR - https://doi.org/10.1136/annrheumdis-2015-207526 DO - 10.1136/annrheumdis-2015-207526 ID - Stoffer2016 ER - TY - JOUR AU - Hamann, P. AU - Holland, R. AU - Hyrich, K. AU - Pauling, J. D. AU - Shaddick, G. AU - Nightingale, A. PY - 2017 DA - 2017// TI - Factors associated with sustained remission in rheumatoid arthritis in patients treated with anti-tumor necrosis factor JO - Arthritis Care Res VL - 69 UR - https://doi.org/10.1002/acr.23016 DO - 10.1002/acr.23016 ID - Hamann2017 ER - TY - JOUR AU - Katchamart, W. AU - Johnson, S. AU - Lin, H. J. AU - Phumethum, V. AU - Salliot, C. AU - Bombardier, C. PY - 2010 DA - 2010// TI - Predictors for remission in rheumatoid arthritis patients: a systematic review JO - Arthritis Care Res VL - 62 UR - https://doi.org/10.1002/acr.20188 DO - 10.1002/acr.20188 ID - Katchamart2010 ER - TY - JOUR AU - Pincus, T. AU - Castrejon, I. AU - Bergman, M. J. AU - Yazici, Y. PY - 2012 DA - 2012// TI - Treat-to-target: not as simple as it appears JO - Clin Exp Rheumatol VL - 30 ID - Pincus2012 ER - TY - JOUR AU - Solomon, D. H. B. A. AU - Katz, J. N. AU - Radner, H. AU - Brown, E. M. AU - Fraenkel, L. PY - 2014 DA - 2014// TI - Review: treat to target in rheumatoid arthritis: fact, fiction, or hypothesis? JO - Arthritis Rheumatol VL - 66 UR - https://doi.org/10.1002/art.38323 DO - 10.1002/art.38323 ID - Solomon2014 ER - TY - STD TI - Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from http://handbook.cochrane.org. UR - http://handbook.cochrane.org ID - ref25 ER - TY - JOUR AU - Sterne, J. A. AU - Sutton, A. J. AU - Ioannidis, J. P. AU - Terrin, N. AU - Jones, D. R. AU - Lau, J. PY - 2011 DA - 2011// TI - Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials JO - BMJ VL - 343 UR - https://doi.org/10.1136/bmj.d4002 DO - 10.1136/bmj.d4002 ID - Sterne2011 ER - TY - JOUR AU - DerSimonian, R. AU - Laird, N. PY - 1986 DA - 1986// TI - Meta-analysis in clinical trials JO - Control Clin Trials VL - 7 UR - https://doi.org/10.1016/0197-2456(86)90046-2 DO - 10.1016/0197-2456(86)90046-2 ID - DerSimonian1986 ER - TY - JOUR AU - Atsumi, T. AU - Yamamoto, K. AU - Takeuchi, T. AU - Yamanaka, H. AU - Ishiguro, N. AU - Tanaka, Y. PY - 2016 DA - 2016// TI - The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression JO - Ann Rheum Dis VL - 75 UR - https://doi.org/10.1136/annrheumdis-2015-207511 DO - 10.1136/annrheumdis-2015-207511 ID - Atsumi2016 ER - TY - JOUR AU - Bakker, M. F. AU - Jacobs, J. W. AU - Welsing, P. M. AU - Verstappen, S. M. AU - Tekstra, J. AU - Ton, E. PY - 2012 DA - 2012// TI - Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial JO - Ann Intern Med VL - 156 UR - https://doi.org/10.7326/0003-4819-156-5-201203060-00004 DO - 10.7326/0003-4819-156-5-201203060-00004 ID - Bakker2012 ER - TY - JOUR AU - Bijlsma, J. W. J. AU - Welsing, P. M. J. AU - Woodworth, T. G. AU - Middelink, L. M. AU - Petho-Schramm, A. AU - Bernasconi, C. PY - 2016 DA - 2016// TI - Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-act-early): a multicentre, randomised, double-blind, double-dummy, strategy trial JO - Lancet VL - 388 UR - https://doi.org/10.1016/S0140-6736(16)30363-4 DO - 10.1016/S0140-6736(16)30363-4 ID - Bijlsma2016 ER - TY - JOUR AU - Breedveld, F. C. AU - Weisman, M. H. AU - Kavanaugh, A. F. AU - Cohen, S. B. AU - Pavelka, K. AU - van Vollenhoven, R. PY - 2006 DA - 2006// TI - The PREMIER study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment JO - Arthritis Rheum VL - 54 UR - https://doi.org/10.1002/art.21519 DO - 10.1002/art.21519 ID - Breedveld2006 ER - TY - JOUR AU - Burmester, G. R. AU - Rigby, W. F. AU - van Vollenhoven, R. F. AU - Kay, J. AU - Rubbert-Roth, A. AU - Kelman, A. PY - 2016 DA - 2016// TI - Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trial JO - Ann Rheum Dis VL - 75 UR - https://doi.org/10.1136/annrheumdis-2015-207628 DO - 10.1136/annrheumdis-2015-207628 ID - Burmester2016 ER - TY - JOUR AU - Capell, H. A. AU - Madhok, R. AU - Porter, D. R. AU - Munro, R. A. AU - McInnes, I. B. AU - Hunter, J. A. PY - 2007 DA - 2007// TI - Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study JO - Ann Rheum Dis VL - 66 UR - https://doi.org/10.1136/ard.2006.057133 DO - 10.1136/ard.2006.057133 ID - Capell2007 ER - TY - JOUR AU - Cohen, S. B. AU - Emery, P. AU - Greenwald, M. W. AU - Dougados, M. AU - Furie, R. A. AU - Genovese, M. C. PY - 2006 DA - 2006// TI - Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks JO - Arthritis Rheum VL - 54 UR - https://doi.org/10.1002/art.22025 DO - 10.1002/art.22025 ID - Cohen2006 ER - TY - JOUR AU - Detert, J. AU - Bastian, H. AU - Listing, J. AU - Weiss, A. AU - Wassenberg, S. AU - Liebhaber, A. PY - 2013 DA - 2013// TI - Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naive patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated study JO - Ann Rheum Dis VL - 72 UR - https://doi.org/10.1136/annrheumdis-2012-201612 DO - 10.1136/annrheumdis-2012-201612 ID - Detert2013 ER - TY - JOUR AU - Dougados, M. AU - Kissel, K. AU - Sheeran, T. AU - Tak, P. P. AU - Conaghan, P. G. AU - Mola, E. M. PY - 2013 DA - 2013// TI - Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY) JO - Ann Rheum Dis VL - 72 UR - https://doi.org/10.1136/annrheumdis-2011-201282 DO - 10.1136/annrheumdis-2011-201282 ID - Dougados2013 ER - TY - JOUR AU - Emery, P. B. G. AU - Bykerk, V. P. AU - Combe, B. G. AU - Furst, D. E. AU - Barre, E. AU - Karyekar, C. S. PY - 2015 DA - 2015// TI - Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month double-blind treatment period JO - Ann Rheum Dis VL - 74 UR - https://doi.org/10.1136/annrheumdis-2014-206106 DO - 10.1136/annrheumdis-2014-206106 ID - Emery2015 ER - TY - JOUR AU - Emery, P. AU - Breedveld, F. C. AU - Hall, S. AU - Durez, P. AU - Chang, D. J. AU - Robertson, D. PY - 2008 DA - 2008// TI - Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial JO - Lancet VL - 372 UR - https://doi.org/10.1016/S0140-6736(08)61000-4 DO - 10.1016/S0140-6736(08)61000-4 ID - Emery2008 ER - TY - JOUR AU - Emery, P. AU - Fleischmann, R. M. AU - Moreland, L. W. AU - Hsia, E. C. AU - Strusberg, I. AU - Durez, P. PY - 2009 DA - 2009// TI - Golimumab, a human anti-tumor necrosis factor alpha monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: twenty-four-week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis JO - Arthritis Rheum VL - 60 UR - https://doi.org/10.1002/art.24638 DO - 10.1002/art.24638 ID - Emery2009 ER - TY - JOUR AU - Emery, P. AU - Keystone, E. AU - Tony, H. P. AU - Cantagrel, A. AU - van Vollenhoven, R. AU - Sanchez, A. PY - 2008 DA - 2008// TI - IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial JO - Ann Rheum Dis VL - 67 UR - https://doi.org/10.1136/ard.2008.092932 DO - 10.1136/ard.2008.092932 ID - Emery2008 ER - TY - JOUR AU - Emery, P. AU - Deodhar, A. AU - Rigby, W. F. AU - Isaacs, J. D. AU - Combe, B. AU - Racewicz, A. J. PY - 2010 DA - 2010// TI - Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (study evaluating Rituximab's efficacy in MTX iNadequate rEsponders (SERENE)) JO - Ann Rheum Dis VL - 69 UR - https://doi.org/10.1136/ard.2009.119933 DO - 10.1136/ard.2009.119933 ID - Emery2010 ER - TY - JOUR AU - Emery, P. AU - Bingham, C. O. AU - Burmester, G. R. AU - Bykerk, V. P. AU - Furst, D. E. AU - Mariette, X. PY - 2017 DA - 2017// TI - Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naive patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III study JO - Ann Rheum Dis VL - 76 UR - https://doi.org/10.1136/annrheumdis-2015-209057 DO - 10.1136/annrheumdis-2015-209057 ID - Emery2017 ER - TY - JOUR AU - Genovese, M. C. AU - Kremer, J. AU - Zamani, O. AU - Ludivico, C. AU - Krogulec, M. AU - al, X. L. PY - 2016 DA - 2016// TI - Baricitinib in patients with refractory rheumatoid arthritis JO - N Engl J Med VL - 374 UR - https://doi.org/10.1056/NEJMoa1507247 DO - 10.1056/NEJMoa1507247 ID - Genovese2016 ER - TY - JOUR AU - Genovese, M. C. AU - McKay, J. D. AU - Nasonov, E. L. AU - Mysler, E. F. AU - da Silva, N. A. AU - Alecock, E. PY - 2008 DA - 2008// TI - Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study JO - Arthritis Rheum VL - 58 UR - https://doi.org/10.1002/art.23940 DO - 10.1002/art.23940 ID - Genovese2008 ER - TY - JOUR AU - Goekoop-Ruiterman, Y. P. AU - de Vries-Bouwstra, J. K. AU - Allaart, C. F. AU - van Zeben, D. AU - Kerstens, P. J. AU - Hazes, J. M. PY - 2005 DA - 2005// TI - Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial JO - Arthritis Rheum VL - 52 UR - https://doi.org/10.1002/art.21405 DO - 10.1002/art.21405 ID - Goekoop-Ruiterman2005 ER - TY - JOUR AU - Grigor, C. AU - Capell, H. AU - Stirling, A. AU - McMahon, A. D. AU - Lock, P. AU - Vallance, R. PY - 2004 DA - 2004// TI - Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial JO - Lancet VL - 364 UR - https://doi.org/10.1016/S0140-6736(04)16676-2 DO - 10.1016/S0140-6736(04)16676-2 ID - Grigor2004 ER - TY - JOUR AU - Hetland, M. L. AU - Stengaard-Pedersen, K. AU - Junker, P. AU - Lottenburger, T. AU - Ellingsen, T. AU - Andersen, L. S. PY - 2006 DA - 2006// TI - Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: an investigator-initiated, multicenter, randomized, double-blind, parallel-group, placebo-controlled study JO - Arthritis Rheum VL - 54 UR - https://doi.org/10.1002/art.21796 DO - 10.1002/art.21796 ID - Hetland2006 ER - TY - JOUR AU - Horslev-Petersen, K. AU - Hetland, M. L. AU - Junker, P. AU - Podenphant, J. AU - Ellingsen, T. AU - Ahlquist, P. PY - 2014 DA - 2014// TI - Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial JO - Ann Rheum Dis VL - 73 UR - https://doi.org/10.1136/annrheumdis-2012-202735 DO - 10.1136/annrheumdis-2012-202735 ID - Horslev-Petersen2014 ER - TY - JOUR AU - Kavanaugh, A. AU - Fleischmann, R. M. AU - Emery, P. AU - Kupper, H. AU - Redden, L. AU - Guerette, B. PY - 2013 DA - 2013// TI - Clinical, functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoid arthritis: 26-week results from the randomised, controlled OPTIMA study JO - Ann Rheum Dis VL - 72 UR - https://doi.org/10.1136/annrheumdis-2011-201247 DO - 10.1136/annrheumdis-2011-201247 ID - Kavanaugh2013 ER - TY - JOUR AU - Kivitz, A. AU - Olech, E. AU - Borofsky, M. AU - Zazueta, B. M. AU - Navarro-Sarabia, F. AU - Radominski SC Bao, M. PY - 2014 DA - 2014// TI - Subcutaneous tocilizumab versus placebo in combination with disease-modifying antirheumatic drugs in patients with rheumatoid arthritis JO - Arthritis Care Res VL - 66 UR - https://doi.org/10.1002/acr.22384 DO - 10.1002/acr.22384 ID - Kivitz2014 ER - TY - JOUR AU - Klareskog, L. AU - van der Heijde, D. AU - de Jager, J. P. AU - Gough, A. AU - Kalden, J. AU - Malaise, M. PY - 2004 DA - 2004// TI - Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial JO - Lancet VL - 363 UR - https://doi.org/10.1016/S0140-6736(04)15640-7 DO - 10.1016/S0140-6736(04)15640-7 ID - Klareskog2004 ER - TY - JOUR AU - Kremer, J. M. AU - Dougados, M. AU - Emery, P. AU - Durez, P. AU - Sibilia, J. AU - Shergy, W. PY - 2005 DA - 2005// TI - Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial JO - Arthritis Rheum VL - 52 UR - https://doi.org/10.1002/art.21201 DO - 10.1002/art.21201 ID - Kremer2005 ER - TY - JOUR AU - Kremer, J. M. AU - Blanco, R. AU - Brzosko, M. AU - Burgos-Vargas, R. AU - Halland, A. M. AU - Vernon, E. PY - 2011 DA - 2011// TI - Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structural joint damage at one year JO - Arthritis Rheum VL - 63 UR - https://doi.org/10.1002/art.30158 DO - 10.1002/art.30158 ID - Kremer2011 ER - TY - JOUR AU - Kremer, J. M. AU - Cohen, S. AU - Wilkinson, B. E. AU - Connell, C. A. AU - French, J. L. AU - Gomez-Reino, J. PY - 2012 DA - 2012// TI - A phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone JO - Arthritis Rheum VL - 64 UR - https://doi.org/10.1002/art.33419 DO - 10.1002/art.33419 ID - Kremer2012 ER - TY - JOUR AU - Kremer, J. AU - Li, Z. G. AU - Hall, S. AU - Fleischmann, R. AU - Genovese, M. AU - Martin-Mola, E. PY - 2013 DA - 2013// TI - Tofacitinib in combination with nonbiologic disease-modifying antirheumatic drugs in patients with active rheumatoid arthritis: a randomized trial JO - Ann Intern Med VL - 159 UR - https://doi.org/10.7326/0003-4819-159-4-201308200-00006 DO - 10.7326/0003-4819-159-4-201308200-00006 ID - Kremer2013 ER - TY - JOUR AU - Nam, J. L. AU - Villeneuve, E. AU - Hensor, E. M. AU - Wakefield, R. J. AU - Conaghan, P. G. AU - Green, M. J. PY - 2014 DA - 2014// TI - A randomised controlled trial of etanercept and methotrexate to induce remission in early inflammatory arthritis: the EMPIRE trial JO - Ann Rheum Dis VL - 73 UR - https://doi.org/10.1136/annrheumdis-2013-204882 DO - 10.1136/annrheumdis-2013-204882 ID - Nam2014 ER - TY - JOUR AU - Nam, J. L. AU - Villeneuve, E. AU - Hensor, E. M. A. AU - Conaghan, P. G. AU - Keen, H. I. AU - Buch, M. H. AU - Gough, A. K. AU - Green, M. J. AU - Helliwell, P. S. AU - Keenan, A. M. AU - Morgan, A. W. AU - Quinn, M. AU - Reece, R. AU - van der Heijde, D. M. AU - Wakefield, R. J. AU - Emery, P. PY - 2013 DA - 2013// TI - Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study) JO - Annals of the Rheumatic Diseases VL - 73 UR - https://doi.org/10.1136/annrheumdis-2013-203440 DO - 10.1136/annrheumdis-2013-203440 ID - Nam2013 ER - TY - JOUR AU - Schiff, M. AU - Keiserman, M. AU - Codding, C. AU - Songcharoen, S. AU - Berman, A. AU - Nayiager, S. PY - 2008 DA - 2008// TI - Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-Centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate JO - Ann Rheum Dis VL - 67 UR - https://doi.org/10.1136/ard.2007.080002 DO - 10.1136/ard.2007.080002 ID - Schiff2008 ER - TY - JOUR AU - Schipper, L. G. AU - Vermeer, M. AU - Kuper, H. H. AU - Hoekstra, M. O. AU - Haagsma, C. J. AU - Den Broeder, A. A. PY - 2012 DA - 2012// TI - A tight control treatment strategy aiming for remission in early rheumatoid arthritis is more effective than usual care treatment in daily clinical practice: a study of two cohorts in the Dutch rheumatoid arthritis monitoring registry JO - Ann Rheum Dis VL - 71 UR - https://doi.org/10.1136/annrheumdis-2011-200274 DO - 10.1136/annrheumdis-2011-200274 ID - Schipper2012 ER - TY - JOUR AU - Smolen, J. S. AU - Emery, P. AU - Ferraccioli, G. F. AU - Samborski, W. AU - Berenbaum, F. AU - Davies, O. R. PY - 2015 DA - 2015// TI - Certolizumab pegol in rheumatoid arthritis patients with low to moderate activity: the CERTAIN double-blind, randomised, placebo-controlled trial JO - Ann Rheum Dis VL - 74 UR - https://doi.org/10.1136/annrheumdis-2013-204632 DO - 10.1136/annrheumdis-2013-204632 ID - Smolen2015 ER - TY - JOUR AU - Smolen, J. S. AU - Kay, J. AU - Doyle, M. K. AU - Landewe, R. AU - Matteson, E. L. AU - Wollenhaupt, J. PY - 2009 DA - 2009// TI - Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial JO - Lancet VL - 374 UR - https://doi.org/10.1016/S0140-6736(09)60506-7 DO - 10.1016/S0140-6736(09)60506-7 ID - Smolen2009 ER - TY - JOUR AU - Smolen, J. S. AU - Beaulieu, A. AU - Rubbert-Roth, A. AU - Ramos-Remus, C. AU - Rovensky, J. AU - Alecock, E. PY - 2008 DA - 2008// TI - Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial JO - Lancet VL - 371 UR - https://doi.org/10.1016/S0140-6736(08)60453-5 DO - 10.1016/S0140-6736(08)60453-5 ID - Smolen2008 ER - TY - JOUR AU - Smolen, J. AU - Landewe, R. B. AU - Mease, P. AU - Brzezicki, J. AU - Mason, D. AU - Luijtens, K. PY - 2009 DA - 2009// TI - Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial JO - Ann Rheum Dis VL - 68 UR - https://doi.org/10.1136/ard.2008.101659 DO - 10.1136/ard.2008.101659 ID - Smolen2009 ER - TY - JOUR AU - Soubrier, M. AU - Puechal, X. AU - Sibilia, J. AU - Mariette, X. AU - Meyer, O. AU - Combe, B. PY - 2009 DA - 2009// TI - Evaluation of two strategies (initial methotrexate monotherapy vs its combination with adalimumab) in management of early active rheumatoid arthritis: data from the GUEPARD trial JO - Rheumatology VL - 48 UR - https://doi.org/10.1093/rheumatology/kep261 DO - 10.1093/rheumatology/kep261 ID - Soubrier2009 ER - TY - JOUR AU - St Clair, E. W. AU - van der Heijde, D. M. AU - Smolen, J. S. AU - Maini, R. N. AU - Bathon, J. M. AU - Emery, P. PY - 2004 DA - 2004// TI - Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial JO - Arthritis Rheum VL - 50 UR - https://doi.org/10.1002/art.20568 DO - 10.1002/art.20568 ID - St Clair2004 ER - TY - JOUR AU - Symmons, D. AU - Tricker, K. AU - Harrison, M. AU - Roberts, C. AU - Davis, M. AU - Dawes, P. PY - 2006 DA - 2006// TI - Patients with stable long-standing rheumatoid arthritis continue to deteriorate despite intensified treatment with traditional disease modifying anti-rheumatic drugs--results of the British rheumatoid outcome study group randomized controlled clinical trial JO - Rheumatology VL - 45 UR - https://doi.org/10.1093/rheumatology/kei169 DO - 10.1093/rheumatology/kei169 ID - Symmons2006 ER - TY - JOUR AU - Tak, P. P. AU - Rigby, W. F. AU - Rubbert-Roth, A. AU - Peterfy, C. G. AU - van Vollenhoven, R. F. AU - Stohl, W. PY - 2011 DA - 2011// TI - Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial JO - Ann Rheum Dis VL - 70 UR - https://doi.org/10.1136/ard.2010.137703 DO - 10.1136/ard.2010.137703 ID - Tak2011 ER - TY - JOUR AU - Takeuchi, T. AU - Yamanaka, H. AU - Ishiguro, N. AU - Miyasaka, N. AU - Mukai, M. AU - Matsubara, T. PY - 2014 DA - 2014// TI - Adalimumab, a human anti-TNF monoclonal antibody, outcome study for the prevention of joint damage in Japanese patients with early rheumatoid arthritis: the HOPEFUL 1 study JO - Ann Rheum Dis VL - 73 UR - https://doi.org/10.1136/annrheumdis-2012-202433 DO - 10.1136/annrheumdis-2012-202433 ID - Takeuchi2014 ER - TY - JOUR AU - Taylor, P. C. AU - Keystone, E. C. AU - van der Heijde, D. AU - Weinblatt, M. E. AU - Del Carmen Morales, L. AU - Reyes Gonzaga, J. PY - 2017 DA - 2017// TI - Baricitinib versus placebo or adalimumab in rheumatoid arthritis JO - N Engl J Med VL - 376 UR - https://doi.org/10.1056/NEJMoa1608345 DO - 10.1056/NEJMoa1608345 ID - Taylor2017 ER - TY - JOUR AU - van der Heijde, D. AU - Tanaka, Y. AU - Fleischmann, R. AU - Keystone, E. AU - Kremer, J. AU - Zerbini, C. PY - 2013 DA - 2013// TI - Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: twelve-month data from a twenty-four-month phase III randomized radiographic study JO - Arthritis Rheum VL - 65 UR - https://doi.org/10.1002/art.37816 DO - 10.1002/art.37816 ID - van der Heijde2013 ER - TY - JOUR AU - van Eijk, I. C. AU - Nielen, M. M. AU - van der Horst-Bruinsma, I. AU - Tijhuis, G. J. AU - Boers, M. AU - Dijkmans, B. A. PY - 2012 DA - 2012// TI - Aggressive therapy in patients with early arthritis results in similar outcome compared with conventional care: the STREAM randomized trial JO - Rheumatology VL - 51 UR - https://doi.org/10.1093/rheumatology/ker355 DO - 10.1093/rheumatology/ker355 ID - van Eijk2012 ER - TY - JOUR AU - van Vollenhoven, R. F. AU - Fleischmann, R. AU - Cohen, S. AU - Lee, E. B. AU - Garcia Meijide, J. A. AU - Wagner, S. PY - 2012 DA - 2012// TI - Tofacitinib or adalimumab versus placebo in rheumatoid arthritis JO - N Engl J Med VL - 367 UR - https://doi.org/10.1056/NEJMoa1112072 DO - 10.1056/NEJMoa1112072 ID - van Vollenhoven2012 ER - TY - JOUR AU - Verstappen, S. M. AU - Jacobs, J. W. AU - van der Veen, M. J. AU - Heurkens, A. H. AU - Schenk, Y. AU - ter Borg, E. J. PY - 2007 DA - 2007// TI - Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial) JO - Ann Rheum Dis VL - 66 UR - https://doi.org/10.1136/ard.2007.071092 DO - 10.1136/ard.2007.071092 ID - Verstappen2007 ER - TY - JOUR AU - Weinblatt, M. E. AU - Bingham, C. O. AU - Mendelsohn, A. M. AU - Kim, L. AU - Mack, M. AU - Lu, J. AU - Baker, D. PY - 2013 DA - 2013// TI - Intravenous golimumab is effective in patients with active rheumatoid arthritis despite methotrexate therapy with responses as early as week 2: results of the phase 3, randomised, multicentre, double-blind, placebo-controlled GO-FURTHER trial JO - Ann Rheum Dis VL - 72 UR - https://doi.org/10.1136/annrheumdis-2012-201411 DO - 10.1136/annrheumdis-2012-201411 ID - Weinblatt2013 ER - TY - JOUR AU - Westhovens, R. AU - Robles, M. AU - Ximenes, A. C. AU - Nayiager, S. AU - Wollenhaupt, J. AU - Durez, P. PY - 2009 DA - 2009// TI - Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors JO - Ann Rheum Dis VL - 68 UR - https://doi.org/10.1136/ard.2008.101121 DO - 10.1136/ard.2008.101121 ID - Westhovens2009 ER - TY - JOUR AU - Heimans, L. AU - Wevers-de Boer, K. V. AU - Visser, K. AU - Goekoop, R. J. AU - van Oosterhout, M. AU - Harbers, J. B. PY - 2014 DA - 2014// TI - A two-step treatment strategy trial in patients with early arthritis aimed at achieving remission: the IMPROVED study JO - Ann Rheum Dis VL - 73 UR - https://doi.org/10.1136/annrheumdis-2013-203243 DO - 10.1136/annrheumdis-2013-203243 ID - Heimans2014 ER - TY - JOUR AU - Leirisalo-Repo, M. AU - Kautiainen, H. AU - Laasonen, L. AU - Korpela, M. AU - Kauppi, M. J. AU - Kaipiainen-Seppanen, O. PY - 2013 DA - 2013// TI - Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo study) JO - Ann Rheum Dis VL - 72 UR - https://doi.org/10.1136/annrheumdis-2012-201365 DO - 10.1136/annrheumdis-2012-201365 ID - Leirisalo-Repo2013 ER - TY - JOUR AU - O'Dell, J. R. AU - Mikuls, T. R. AU - Taylor, T. H. AU - Ahluwalia, V. AU - Brophy, M. AU - Warren, S. R. PY - 2013 DA - 2013// TI - Therapies for active rheumatoid arthritis after methotrexate failure JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMoa1303006 DO - 10.1056/NEJMoa1303006 ID - O'Dell2013 ER - TY - JOUR AU - Scott, D. L. AU - Ibrahim, F. AU - Farewell, V. AU - O'Keeffe, A. G. AU - Walker, D. AU - Kelly, C. PY - 2015 DA - 2015// TI - Tumour necrosis factor inhibitors versus combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: TACIT non-inferiority randomised controlled trial JO - BMJ VL - 350 UR - https://doi.org/10.1136/bmj.h1046 DO - 10.1136/bmj.h1046 ID - Scott2015 ER - TY - JOUR AU - Moreland, L. W. AU - O'Dell, J. R. AU - Paulus, H. E. AU - Curtis, J. R. AU - Bathon, J. M. AU - St Clair, E. W. PY - 2012 DA - 2012// TI - A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of early aggressive rheumatoid arthritis trial JO - Arthritis Rheum VL - 64 UR - https://doi.org/10.1002/art.34498 DO - 10.1002/art.34498 ID - Moreland2012 ER - TY - JOUR AU - Scott, D. L. PY - 2011 DA - 2011// TI - Role of spleen tyrosine kinase inhibitors in the management of rheumatoid arthritis JO - Drugs VL - 71 UR - https://doi.org/10.2165/11591480-000000000-00000 DO - 10.2165/11591480-000000000-00000 ID - Scott2011 ER - TY - STD TI - Rau R, Sander O, van Riel P, van de Putte L, Hasler F, Zaug M, et al. Intravenous human recombinant tumor necrosis factor receptor p55-fc IgG1 fusion protein Ro 45-2081 (lenercept): a double blind, placebo controlled dose finding study in rheumatoid arthritis. J Rheumatol. 2003;30:680–90. ID - ref82 ER - TY - JOUR AU - Felson, D. a. v. i. d. T. AU - Anderson, J. e. n. n. i. f. e. r. J. AU - Meenan, R. o. b. e. r. t. F. PY - 1994 DA - 1994// TI - The efficacy and toxicity of combination therapy in rheumatoid arthritis. a meta-analysis JO - Arthritis & Rheumatism VL - 37 UR - https://doi.org/10.1002/art.1780371012 DO - 10.1002/art.1780371012 ID - Felson1994 ER - TY - STD TI - (NICE). NIfHaCE: Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed. https://www.nice.org.uk/guidance/ta375 UR - https://www.nice.org.uk/guidance/ta375 ID - ref84 ER -